Copyright Reports & Markets. All rights reserved.

Global IVD Infectious Diseases Market Growth (Status and Outlook) 2019-2024

Buy now

Table of Contents

    2019-2024 Global IVD Infectious Diseases Market Report (Status and Outlook)

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global IVD Infectious Diseases Market Size 2014-2024
        • 2.1.2 IVD Infectious Diseases Market Size CAGR by Region
      • 2.2 IVD Infectious Diseases Segment by Type
        • 2.2.1 Immunochemistry
        • 2.2.2 Molecular Diagnostics
      • 2.3 IVD Infectious Diseases Market Size by Type
        • 2.3.1 Global IVD Infectious Diseases Market Size Market Share by Type (2014-2019)
        • 2.3.2 Global IVD Infectious Diseases Market Size Growth Rate by Type (2014-2019)
      • 2.4 IVD Infectious Diseases Segment by Application
        • 2.4.1 Clinical Laboratories
        • 2.4.2 Diagnostic Centers
      • 2.5 IVD Infectious Diseases Market Size by Application
        • 2.5.1 Global IVD Infectious Diseases Market Size Market Share by Application (2014-2019)
        • 2.5.2 Global IVD Infectious Diseases Market Size Growth Rate by Application (2014-2019)

      3 Global IVD Infectious Diseases by Players

      • 3.1 Global IVD Infectious Diseases Market Size Market Share by Players
        • 3.1.1 Global IVD Infectious Diseases Market Size by Players (2017-2019)
        • 3.1.2 Global IVD Infectious Diseases Market Size Market Share by Players (2017-2019)
      • 3.2 Global IVD Infectious Diseases Key Players Head office and Products Offered
      • 3.3 Market Concentration Rate Analysis
        • 3.3.1 Competition Landscape Analysis
        • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.4 New Products and Potential Entrants
      • 3.5 Mergers & Acquisitions, Expansion

      4 IVD Infectious Diseases by Regions

      • 4.1 IVD Infectious Diseases Market Size by Regions
      • 4.2 Americas IVD Infectious Diseases Market Size Growth
      • 4.3 APAC IVD Infectious Diseases Market Size Growth
      • 4.4 Europe IVD Infectious Diseases Market Size Growth
      • 4.5 Middle East & Africa IVD Infectious Diseases Market Size Growth

      5 Americas

      • 5.1 Americas IVD Infectious Diseases Market Size by Countries
      • 5.2 Americas IVD Infectious Diseases Market Size by Type
      • 5.3 Americas IVD Infectious Diseases Market Size by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC IVD Infectious Diseases Market Size by Countries
      • 6.2 APAC IVD Infectious Diseases Market Size by Type
      • 6.3 APAC IVD Infectious Diseases Market Size by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe IVD Infectious Diseases by Countries
      • 7.2 Europe IVD Infectious Diseases Market Size by Type
      • 7.3 Europe IVD Infectious Diseases Market Size by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa IVD Infectious Diseases by Countries
      • 8.2 Middle East & Africa IVD Infectious Diseases Market Size by Type
      • 8.3 Middle East & Africa IVD Infectious Diseases Market Size by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Global IVD Infectious Diseases Market Forecast

      • 10.1 Global IVD Infectious Diseases Market Size Forecast (2019-2024)
      • 10.2 Global IVD Infectious Diseases Forecast by Regions
        • 10.2.1 Global IVD Infectious Diseases Forecast by Regions (2019-2024)
        • 10.2.2 Americas Market Forecast
        • 10.2.3 APAC Market Forecast
        • 10.2.4 Europe Market Forecast
        • 10.2.5 Middle East & Africa Market Forecast
      • 10.3 Americas Forecast by Countries
        • 10.3.1 United States Market Forecast
        • 10.3.2 Canada Market Forecast
        • 10.3.3 Mexico Market Forecast
        • 10.3.4 Brazil Market Forecast
      • 10.4 APAC Forecast by Countries
        • 10.4.1 China Market Forecast
        • 10.4.2 Japan Market Forecast
        • 10.4.3 Korea Market Forecast
        • 10.4.4 Southeast Asia Market Forecast
        • 10.4.5 India Market Forecast
        • 10.4.6 Australia Market Forecast
      • 10.5 Europe Forecast by Countries
        • 10.5.1 Germany Market Forecast
        • 10.5.2 France Market Forecast
        • 10.5.3 UK Market Forecast
        • 10.5.4 Italy Market Forecast
        • 10.5.5 Russia Market Forecast
        • 10.5.6 Spain Market Forecast
      • 10.6 Middle East & Africa Forecast by Countries
        • 10.6.1 Egypt Market Forecast
        • 10.6.2 South Africa Market Forecast
        • 10.6.3 Israel Market Forecast
        • 10.6.4 Turkey Market Forecast
        • 10.6.5 GCC Countries Market Forecast
      • 10.7 Global IVD Infectious Diseases Forecast by Type
      • 10.8 Global IVD Infectious Diseases Forecast by Application

      11 Key Players Analysis

      • 11.1 BD
        • 11.1.1 Company Details
        • 11.1.2 IVD Infectious Diseases Product Offered
        • 11.1.3 BD IVD Infectious Diseases Revenue, Gross Margin and Market Share (2017-2019)
        • 11.1.4 Main Business Overview
        • 11.1.5 BD News
      • 11.2 BioMerieux
        • 11.2.1 Company Details
        • 11.2.2 IVD Infectious Diseases Product Offered
        • 11.2.3 BioMerieux IVD Infectious Diseases Revenue, Gross Margin and Market Share (2017-2019)
        • 11.2.4 Main Business Overview
        • 11.2.5 BioMerieux News
      • 11.3 Abbott
        • 11.3.1 Company Details
        • 11.3.2 IVD Infectious Diseases Product Offered
        • 11.3.3 Abbott IVD Infectious Diseases Revenue, Gross Margin and Market Share (2017-2019)
        • 11.3.4 Main Business Overview
        • 11.3.5 Abbott News
      • 11.4 Quidel
        • 11.4.1 Company Details
        • 11.4.2 IVD Infectious Diseases Product Offered
        • 11.4.3 Quidel IVD Infectious Diseases Revenue, Gross Margin and Market Share (2017-2019)
        • 11.4.4 Main Business Overview
        • 11.4.5 Quidel News
      • 11.5 Gen-Probe
        • 11.5.1 Company Details
        • 11.5.2 IVD Infectious Diseases Product Offered
        • 11.5.3 Gen-Probe IVD Infectious Diseases Revenue, Gross Margin and Market Share (2017-2019)
        • 11.5.4 Main Business Overview
        • 11.5.5 Gen-Probe News
      • 11.6 Alere
        • 11.6.1 Company Details
        • 11.6.2 IVD Infectious Diseases Product Offered
        • 11.6.3 Alere IVD Infectious Diseases Revenue, Gross Margin and Market Share (2017-2019)
        • 11.6.4 Main Business Overview
        • 11.6.5 Alere News
      • 11.7 Danaher
        • 11.7.1 Company Details
        • 11.7.2 IVD Infectious Diseases Product Offered
        • 11.7.3 Danaher IVD Infectious Diseases Revenue, Gross Margin and Market Share (2017-2019)
        • 11.7.4 Main Business Overview
        • 11.7.5 Danaher News
      • 11.8 Sysmex
        • 11.8.1 Company Details
        • 11.8.2 IVD Infectious Diseases Product Offered
        • 11.8.3 Sysmex IVD Infectious Diseases Revenue, Gross Margin and Market Share (2017-2019)
        • 11.8.4 Main Business Overview
        • 11.8.5 Sysmex News
      • 11.9 Orasure
        • 11.9.1 Company Details
        • 11.9.2 IVD Infectious Diseases Product Offered
        • 11.9.3 Orasure IVD Infectious Diseases Revenue, Gross Margin and Market Share (2017-2019)
        • 11.9.4 Main Business Overview
        • 11.9.5 Orasure News
      • 11.10 Hologic
        • 11.10.1 Company Details
        • 11.10.2 IVD Infectious Diseases Product Offered
        • 11.10.3 Hologic IVD Infectious Diseases Revenue, Gross Margin and Market Share (2017-2019)
        • 11.10.4 Main Business Overview
        • 11.10.5 Hologic News
      • 11.11 Cepheid
      • 11.12 Qiagen
      • 11.13 Roche Diagnostics
      • 11.14 Siemens Healthcare
      • 11.15 Bio-Rad Laboratories

      12 Research Findings and Conclusion

      In Vitro Diagnostics (IVDs) are medical devices and accessories used to perform tests on samples, (e.g., blood, urine and tissue that has been taken from the human body) in order to help detect infection, Diagnose a medical condition and Prevent disease.

      According to this study, over the next five years the IVD Infectious Diseases market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in IVD Infectious Diseases business, shared in Chapter 3.

      This report presents a comprehensive overview, market shares and growth opportunities of IVD Infectious Diseases market by product type, application, key companies and key regions.

      This study considers the IVD Infectious Diseases value generated from the sales of the following segments:

      Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
      Immunochemistry
      Molecular Diagnostics
      Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
      Clinical Laboratories
      Diagnostic Centers

      This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
      BD
      BioMerieux
      Abbott
      Quidel
      Gen-Probe
      Alere
      Danaher
      Sysmex
      Orasure
      Hologic
      Cepheid
      Qiagen
      Roche Diagnostics
      Siemens Healthcare
      Bio-Rad Laboratories

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global IVD Infectious Diseases market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
      To understand the structure of IVD Infectious Diseases market by identifying its various subsegments.
      Focuses on the key global IVD Infectious Diseases players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the IVD Infectious Diseases with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the size of IVD Infectious Diseases submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.

      Buy now